HIV/AIDS Co-Infection
Beating the Number-One Killer in AIDS: Tuberculosis
Published in AIDS Weekly, December 29th, 2008
The success of treating HIV/AIDS with antiretroviral therapy has been a good news, bad news proposition. Individuals with HIV and AIDS are living longer due to the success of antiretroviral therapies. While these agents – of which more than twenty have been approved in the U.S. – do an adequate job of keeping the human immunodeficiency virus at bay for long periods, some experts suspect the benefit is not as great as it might be. While fewer people are dying from HIV infection, an alarming number are succumbing to tuberculosis, particularly multiple drug-resistant tuberculosis (MDR TB) and extensively drug-resistant tuberculosis (XR TB).
Once quite treatable, TB has...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
Source: AIDS Weekly (2008-12-29)
More Articles from AIDS Weekly
- Antiretrovirals
Studies from J. Molto and co-authors have provided new information about antiretrovirals - Biotechnology Business
Studies from P. Grant et al have provided new data on biotechnology business - HIV/AIDS
New findings from New York Blood Center describe advances in HIV/AIDS - HIV/AIDS
New HIV/AIDS research from University of Witwatersrand outlined - HIV/AIDS
Reports summarize HIV/AIDS research from Tufts University - HIV/AIDS
Researchers from University of California describe findings in HIV/AIDS - More from this issue of AIDS Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
